Drug Profile
Research programme: neurological and inflammatory disorders - GNT Pharma
Alternative Names: ND-07; NG 2006; Sulfasalazine analogues - GNT PharmaLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Neurotech Pharmaceuticals
- Developer GNT Pharma; Neurotech Pharmaceuticals
- Class Small molecules
- Mechanism of Action Antioxidants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Inflammatory bowel diseases; Pancreatitis; Rheumatoid arthritis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Inflammatory-bowel-disease in South Korea
- 16 Jul 2016 No recent reports of development identified for preclinical development in Pancreatitis in South Korea
- 28 Feb 2011 No development reported for Rheumatoid arthritis in South Korea (unspecified route)